Hyperbaric Oxygen Therapy- for Urinary Tract Infection (HBOTCICrUTI Trial)

Phase < 1

Waitlist Available

Led By Ian R Grover, MD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up three year study period. determination of this endpoint will be made for each individual patient at one year after final hbot session.

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing if breathing pure oxygen in a pressurized chamber can help people with chronic bladder conditions that are hard to treat. The goal is to see if this method can reduce symptoms and be a feasible treatment option. Hyperbaric oxygen therapy (HBO) has been used successfully in several urologic disorders, including painful bladder syndrome/interstitial cystitis and radiation cystitis.

Eligible Conditions

Urinary Tract Infection
Interstitial Cystitis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ three year study period. determination is made for this endpoint on the date of final hbot session.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~three year study period. determination is made for this endpoint on the date of final hbot session.

This trial's timeline: 3 weeks for screening, Varies for treatment, and three year study period. determination is made for this endpoint on the date of final hbot session. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

HBOT acceptance

HBOT adherence

Secondary study objectives

Post treatment incidence of recurrent urinary tract infection.

Interstitial Cystitis

Pre and post treatment symptom survey fro the chronic interstitial cystitis study group. The patient's overall rating of improvement of symptoms (PORIS) will be used.

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Hyperbaric OxygenExperimental Treatment1 Intervention

Hyperbaric oxygen therapy-2.4 atmosphere absolute for 90 minutes with 2-five minute air breaks administered daily, 5 days per week for 8 weeks total treatment.

Do I qualify?Apply below to find out